144 related articles for article (PubMed ID: 25689044)
1. Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.
Sharma M; Walmsley SL
HIV Med; 2015 Jul; 16(6):329-36. PubMed ID: 25689044
[TBL] [Abstract][Full Text] [Related]
2. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.
Robinson JA; Jamshidi R; Burke AE
Infect Dis Obstet Gynecol; 2012; 2012():890160. PubMed ID: 22927715
[TBL] [Abstract][Full Text] [Related]
3. Reproductive choice for women and men living with HIV: contraception, abortion and fertility.
Delvaux T; Nöstlinger C
Reprod Health Matters; 2007 May; 15(29 Suppl):46-66. PubMed ID: 17531748
[TBL] [Abstract][Full Text] [Related]
4. Effect of hormonal contraceptive methods on HIV disease progression: a systematic review.
Phillips SJ; Curtis KM; Polis CB
AIDS; 2013 Mar; 27(5):787-94. PubMed ID: 23135169
[TBL] [Abstract][Full Text] [Related]
5. Hormonal contraceptive use and risk of HIV-1 disease progression.
Heffron R; Mugo N; Ngure K; Celum C; Donnell D; Were E; Rees H; Kiarie J; Baeten JM;
AIDS; 2013 Jan; 27(2):261-7. PubMed ID: 23079806
[TBL] [Abstract][Full Text] [Related]
6. Women, contraception and STDs including HIV.
Carlin EM; Boag FC
Int J STD AIDS; 1995; 6(6):373-86. PubMed ID: 8845393
[TBL] [Abstract][Full Text] [Related]
7. Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in sub-Saharan Africa.
Stuart GS
Contraception; 2009 Nov; 80(5):412-6. PubMed ID: 19835713
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence.
Polis CB; Phillips SJ; Curtis KM
AIDS; 2013 Feb; 27(4):493-505. PubMed ID: 23079808
[TBL] [Abstract][Full Text] [Related]
10. Current and future contraceptive options for women living with HIV.
Patel RC; Bukusi EA; Baeten JM
Expert Opin Pharmacother; 2018 Jan; 19(1):1-12. PubMed ID: 28891343
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the use of irreversible contraception and continuous use of reversible contraception in a cohort of HIV-positive women.
Kancheva Landolt N; Ramautarsing RA; Phanuphak N; Teeratakulpisarn N; Pinyakorn S; Rodbamrung P; Chaithongwongwatthana S; Ananworanich J
Contraception; 2013 Jul; 88(1):67-73. PubMed ID: 23177263
[TBL] [Abstract][Full Text] [Related]
12. A family planning intervention to reduce vertical transmission of HIV in Rwanda.
King R; Estey J; Allen S; Kegeles S; Wolf W; Valentine C; Serufilira A
AIDS; 1995 Jul; 9 Suppl 1():S45-51. PubMed ID: 8562000
[TBL] [Abstract][Full Text] [Related]
13. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
[TBL] [Abstract][Full Text] [Related]
14. The pregnancy decisions of HIV-positive women: the state of knowledge and way forward.
MacCarthy S; Rasanathan JJ; Ferguson L; Gruskin S
Reprod Health Matters; 2012 Dec; 20(39 Suppl):119-40. PubMed ID: 23177686
[TBL] [Abstract][Full Text] [Related]
15. Contraception in the context of HIV/AIDS: a review.
Agboghoroma CO
Afr J Reprod Health; 2011 Sep; 15(3):15-23. PubMed ID: 22574489
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive methods and risk of HIV acquisition or female-to-male transmission.
Haddad LB; Polis CB; Sheth AN; Brown J; Kourtis AP; King C; Chakraborty R; Ofotokun I
Curr HIV/AIDS Rep; 2014 Dec; 11(4):447-58. PubMed ID: 25297973
[TBL] [Abstract][Full Text] [Related]
17. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
El-Ibiary SY; Cocohoba JM
Eur J Contracept Reprod Health Care; 2008 Jun; 13(2):123-32. PubMed ID: 18465473
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
Pyra M; Heffron R; Mugo NR; Nanda K; Thomas KK; Celum C; Kourtis AP; Were E; Rees H; Bukusi E; Baeten JM;
AIDS; 2015 Nov; 29(17):2353-9. PubMed ID: 26544706
[TBL] [Abstract][Full Text] [Related]
19. Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV.
Scarsi KK; Darin KM; Chappell CA; Nitz SM; Lamorde M
Drug Saf; 2016 Nov; 39(11):1053-1072. PubMed ID: 27562873
[TBL] [Abstract][Full Text] [Related]
20. Contraception for HIV-Infected Adolescents.
Kourtis AP; Mirza A;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27573084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
